Patient Safety & Quality Healthcare (PSQH) discussed IV infiltration and it’s potential for life-threatening consequences in a recent article. The piece, “Companies Work to Help Combat IV Infiltrations” includes commentary from ivWatch President and CEO, Gary Warren, and cites the ivWatch Model 400 as a clinician partner helping to deliver improved patient care with constant monitoring of the IV site. Read the full article here.
Barby took one of the scariest moments of her life and turned it into an opportunity to advocate for herself and others. During #patientrecognitionweek ivWatch recognizes Barby & her journey to becoming a cheerleader of hope. See her courageous story here: https://ivwat.ch/PatientStories
We're proud to expand our intellectual property and trademark portfolios into a wider international market. These protections mean we can deliver on ivWatch's mission to eliminate IV related injuries to patients in Europe, Israel and Japan. Read more here: https://ivwat.ch/Global
We are pleased to announce our participation in @VirginiaExports's VALET Program. Support from the VALET program will aid in ivWatch's continued globalization plan. Read more about the ivWatch and the VALET program here: https://ivwat.ch/VALET